2021 Keynote Information
Celebrating its 12th successful year, SCOPE Summit 2021 takes place March 2-4, 2021 as a fully virtual event. During these difficult times of a global pandemic, the work this clinical research community does is more important than ever and requires collaboration
and innovation. Over the course of three stimulating days of in-depth discussions in 23 different conferences, 5 plenary keynote sessions, the 5th annual Participant Engagement Awards, the new China Clinical Development Partnering event and the ever-popular
interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations, including: De-Centralized Trials, Site Selection and Management, Patient
Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Telemedicine, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD)
in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens,
and Central Lab Solutions, and expanded coverage on Medical Device Clinical Trial Operations and Regulations and Clinical Supply. SCOPE attracted more than 2,200 leaders in clinical operations and research in 2020, and we look forward to you and your
team joining us in the first ever virtual SCOPE!
View All 22 Conference Programs | Breakouts | Participant Engagement Award
TUESDAY, MARCH 2, 2021
8:00 am CASE STUDY: Working Under Pressure COVID-19 Edition: Pfizer’s Vaccine Trial Decision-Making Strategies and Technology-Boosted Operations
Demetris Zambas, Vice President and Global Head,
Data Monitoring and Management, Pfizer
Brett Wilson, Senior Director, Vaccines TA
Lead Data Monitoring & Management, Global Biometrics & Data Management, Global Product Development, Pfizer Inc.
Ralph Russo, Senior Director and Global Head,
Clinical Database Management, Pfizer
Nicholas
Kitchin, MD, Senior Director, Senior Director, Vaccine Clinical Research and Development, Pfizer
Helen Smith, Senior Director, Clinical Study Team Lead, CD and O, Pfizer
Liping Zhang,
Senior Director and Vaccines TA Lead, Statistical Programming and Analysis, Pfizer
Darren Cowan,
Executive Director & Area Head USA, Canada, Pfizer
Beth
Paulukonis, Executive Director, Study Management Group Lead, Clinical Development and Operations, Pfizer
9:30 am FIRESIDE CHAT: Accelerated Drug Development in Response to the Pandemic: Lessons Learned and Key Drivers
Moderator: Deborah Borfitz, Senior Science Writer,
Clinical Research News & Bio-IT World
Ken Getz, MBA, Founder, CISCRP; Deputy Director, Center
for the Study of Drug Development, Tufts University School of Medicine
Leonard Sacks, MD, Acting Deputy Director, Office of Medical Policy, CDER, FDA
3:15 pm SCOPE's 2021 Participant Engagement Awards
CREATIVITY AND ENGAGEMENT IN RECRUITMENT AND RETENTION COMMUNICATIONS
https://www.scopesummit.com/participant-engagement-award
CHAIRPERSON: David Sall, President & CEO, Patient
Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award
Kelly McKee, Senior Director, Patient Recruitment and
Registries, Medidata; Co-Creator of the SCOPE Participant Engagement Award
Phyllis Kaplan, Trial Volunteer and Patient Advocate;
Senior Project Manager, Health Communication Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Ramona Burress, Associate Director, Diversity & Inclusion in Clinical Trials, Janssen R&D LLC
Irfan Khan, MD, CEO, Circuit Clinical - TrialScout
Micah Lieberman, Executive Director, Conferences,
Cambridge Healthtech Institute (CHI)
wednesday, MARCH 3, 2021
10:55 am COVID-19: How an External Event Redoubled Janssen’s Culture of Innovation
Darren Weston, Vice President, Integrated Data
Analytics & Reporting (IDAR), Janssen
11:20 am Option 1 Virtual Investigator Meetings During COVID-19 & Beyond
Steven Sulkin, Founder & CEO, SimuLyve International, Inc
Marina Ziehn, PhD, Global Medical Affairs Director, Novartis Pharmaceuticals
Markus Krüer, MD, Head of Clinical Project Management, Merz Therapeutics
Nico Wegener, MD, Senior Clinical Project Manager, Merz Pharmaceuticals, GmbH
Richard Scher, MD, FACS, Medical Director, Clinical Science, Board Certified Otolaryngologist-Head & Neck Surgeon, Merz Aesthetics, North America
11:20 am Option 2 New Players and Innovators in Clinical Trials, the Impact of Non-Pharma Entrants...Meet Salesforce and CVS Health
Shwen Gwee, VP & Head, Global Digital Strategy, Bristol Myers Squibb Co
Gary Gabriel, PhD, Healthcare and Life Sciences Lead, Salesforce
Lou Sanquini, Vice President, Life Sciences Group, CVS Health
THURSDAY, MARCH 4, 2021
9:00 am INTERACTIVE PANEL: Moving Toward Platform Thinking: Creating a More Seamless Front-End and Back-End to Future-Proof and Advance Digital Transformation in Pharma
Moderator: Adama Ibrahim, EMBA, Director, Digital
Solutions, Novartis
Hassan Kadhim, MBA, Director, Head of Clinical
Trial Business Capabilities, Global Development Operations, Bristol Myers Squibb
Craig Lipset, MBA, Former Head, Clinical Innovation,
Pfizer; Venture Partner, Boston Millennia Partners (BMP) & FundRx; Advisor, People-Centered Research Foundation (PCRF)
Mohammed Ali, VP Digital Analytics & Performance,
GlaxoSmithKline
Disa Lee Choun, Head, GCSO Innovation,
UCB Pharma
11:25 am Option 1 Tokenization of Our Clinical Trial Participants
Kyle Holen, Head, Development Design Center,
AbbVie Inc.
11:25 am Option 2 Social Determinants of Health (SDoH) and Its Relevance to Clinical Trials
Laurie Myers, Director, Global Health Literacy, Merck & Co Inc